Financial Performance - Revenue for Q3 2022 was CNY 510,505,886.53, a decrease of 7.23% compared to the same period last year[5] - Net profit attributable to shareholders was CNY 26,227,101.91, down 43.51% year-on-year[5] - Basic earnings per share decreased by 43.51% to CNY 0.17[5] - Total operating revenue for the period was CNY 1,409,180,215.92, a decrease of 5.9% compared to CNY 1,497,916,499.92 in the previous period[25] - Net profit for the period was CNY 84,116,391.51, a decline of 47.3% compared to CNY 159,383,282.48 in the previous period[26] - Earnings per share decreased to CNY 0.53 from CNY 1.00, reflecting a significant drop in profitability[26] - The total comprehensive income for the period was CNY 84,116,391.51, down from CNY 159,383,282.48, highlighting the overall decline in financial performance[26] Assets and Liabilities - Total assets increased by 16.81% to CNY 1,919,018,749.11 compared to the end of the previous year[5] - Total assets increased to CNY 1,919,018,749.11, up from CNY 1,642,820,235.63, indicating growth in the company's asset base[24] - Total liabilities rose to CNY 663,167,926.93, compared to CNY 439,215,804.96, showing an increase in financial obligations[24] - The company's equity attributable to shareholders increased to CNY 1,233,975,000.40 from CNY 1,181,469,559.75, reflecting a strengthening of shareholder value[24] Cash Flow - Cash flow from operating activities decreased by 63.09% to CNY 82,954,225.28[5] - Operating cash flow for the period was ¥82,954,225.28, a decrease of 63.1% compared to ¥224,724,270.01 in the previous period[27] - Total cash inflow from operating activities was ¥1,541,370,662.38, down 7.1% from ¥1,658,998,331.41 year-on-year[27] - Cash outflow from operating activities totaled ¥1,458,416,437.10, an increase of 1.7% compared to ¥1,434,274,061.40 in the previous period[27] - Cash inflow from financing activities was ¥197,400,000.00, significantly up from ¥43,000,000.00 in the previous period[28] - Net cash flow from financing activities was ¥122,522,793.25, compared to a net outflow of ¥8,921,129.11 in the previous period[28] - The ending balance of cash and cash equivalents was ¥271,942,467.17, an increase from ¥253,302,378.06 in the previous period[28] Expenses - Research and development expenses rose by 35.11% to CNY 12,214,315.18 due to increased salaries for R&D personnel[9] - Operating expenses increased by 38.77% to RMB 3,675,635.90, mainly due to increased losses from the elimination of biological assets[10] - Interest expenses increased by 39.32% to CNY 4,320,030.68 as a result of higher short-term borrowings[9] - Cash paid for dividends and interest increased by 34.46% to RMB 34,238,369.15, attributed to higher dividend distributions and increased interest expenses from short-term loans[10] Inventory and Receivables - Inventory increased by 42.99% to CNY 208,796,409.33 as the company pre-purchased materials in response to market price fluctuations[9] - Accounts receivable increased to CNY 122,268,817.89 from CNY 97,148,358.44, reflecting a growth of approximately 25.9%[22] - Inventory levels rose significantly to CNY 208,796,409.33, compared to CNY 146,016,626.50, marking an increase of around 42.9%[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 18,230[12] - The largest shareholder, Guangdong Yantang Investment Co., Ltd., holds 40.97% of the shares, totaling 64,465,743 shares[12] Future Plans and Agreements - The company plans to collaborate with its controlling shareholder to develop affordable rental housing, transitioning from the previous "three old" renovation project[15] - The company signed a financial service agreement with Guangdong Agricultural Reclamation Group Financial Co., Ltd., with a comprehensive credit of CNY 100,000,000 and a loan of CNY 10,000,000 as of September 30, 2022[18] - The company plans to purchase office properties from Guangzhou Guangken Real Estate Co., Ltd. for a total amount not exceeding CNY 94,640,000, including tax[18] - The estimated transaction amount for purchasing raw materials (sugar) from Guangdong Guangken Sugar Industry Group Co., Ltd. for 2022 is expected to be no more than CNY 21,350,000[17] Related Party Transactions - The company has engaged in daily transactions with related parties, including procurement of raw materials and leasing of properties, all within the expected range[17]
燕塘乳业(002732) - 2022 Q3 - 季度财报